Institute of Science Tokyo · Graduate School of Medical and Dental Sciences

Research keywordspancreatic neuroendocrine neoplasms・capecitabine temozolomide・streptozocin therapy・para-aortic lymph node recurrence・tumor grade and Ki-67

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Yohei Tabe, Daisuke Asano, Hayato Takamizawa, Satoshi Matsui, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Eriko Katsuta, Yuki Kato, Yuko Kinowaki, Daisuke Ban. Late-Onset Para-Aortic Lymph Node Recurrence 11 Years after Resection of Pancreatic Cancer: Histological Reassessment Revealed Neuroendocrine Differentiation Amenable to Surgical Resection. Surg Case Rep. 2025.09; 11 (1): 25-0374. ( PubMed , DOI , 医中誌 )2025
• Yohei Tabe, Hiroaki Ono, Satoshi Matsui, Daisuke Asano, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Eriko Katsuta, Daisuke Ban. Comparative analysis of streptozocin-based regimen and capecitabine-temozolomide therapy in advanced pancreatic neuroendocrine neoplasms: influence of tumor grade and Ki-67 index. Ther Adv Med Oncol. 2025.11; 17 17588359251389742. ( PubMed , DOI )2025

• Official profile